DK
David L Kemmerly
See Remarks

David L Kemmerly insider trades: Amedisys (AMED) stock sales

See Remarks, Amedisys Last trade Mar 29, 2022 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
17
Open-market trades
since 2018
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

17 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 29, 2022AMED↓ Sell$443K
Apr 27, 2021AMED↓ Sell$1.4M
Apr 9, 2021AMED↓ Sell$140K
Apr 1, 2021AMED↓ Sell$136K
Jun 9, 2020AMED↓ Sell$391K
May 5, 2020AMED↓ Sell$4.1M
Feb 25, 2020AMED↓ Sell$247K
Jun 10, 2019AMED↓ Sell$957K
Jun 6, 2019AMED↓ Sell$501K
May 30, 2019AMED↓ Sell$567K
May 20, 2019AMED↓ Sell$550K
May 10, 2019AMED↓ Sell$576K
May 7, 2019AMED↓ Sell$591K
Dec 12, 2018AMED↓ Sell$418K
Nov 14, 2018AMED↓ Sell$365K
Nov 9, 2018AMED↓ Sell$773K
Jun 7, 2018AMED↓ Sell$474K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David L Kemmerly's insider trades

David L Kemmerly is See Remarks at Amedisys (AMED). Since Jun 7, 2018, David has reported no open-market purchases and 17 sales worth $12.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (18 filings), shares withheld for taxes (10 filings), grants and awards (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.